Compound file

Thymosin Alpha 1

Thymosin Alpha 1 is a synthetic 28-amino acid peptide with over 11,000 patients studied across 30+ clinical trials and FDA orphan drug designations for four conditions. It demonstrates exceptional safety with <1% serious adverse events and comprehensive immune system modulation through T-cell activation, NK cell stimulation, and dendritic cell function.